The Technical Analyst
SpectraCure AB (publ) [SPEC.ST]
Exchange: STO Sector: Healthcare Industry: Medical Devices
SpectraCure AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.32% SEK2.87
America/New_York / 17 mai 2024 @ 11:29
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 278.28 mill |
| EPS: | -0.210 |
| P/E: | -13.64 |
| Earnings Date: | N/A |
| SharesOutstanding: | 97.13 mill |
| Avg Daily Volume: | 0.102 mill |
| RATING 2024-05-17 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | n/a | n/a | n/a | n/a | ||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -13.64 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.25x |
| Company: PE -13.64 | industry: PE 54.10 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SEK0.490 (-82.91%) SEK-2.38 |
| Date: 2024-05-18 |
| Expected Trading Range (DAY) |
|---|
|
SEK 2.63 - 3.11 ( +/- 8.33%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - SEK2.87
Forecast 2: 16:00 - SEK2.87
Forecast 3: 16:00 - SEK2.87
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SEK2.87 (2.32% ) |
| Volume | 0.0370 mill |
| Avg. Vol. | 0.102 mill |
| % of Avg. Vol | 36.31 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SPEC.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SPEC.ST
SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.